(Q63397827)
Statements
Secu_in_AD (English)
0 references
A Randomized, Placebo-controlled, Double-blind Study to Scrutinize the Efficacy of Secukinumab in Patients With Moderate to Severe Atopic Dermatitis (English)
0 references
18 September 2018
0 references
September 2019
0 references
45
0 references
18 year
0 references